• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

NCI proposes mammography revisions

Article

The National Cancer Institute last month added fuel to the controversyover mammography screening of women aged 40 to 49. NCI proposeda revision to its breast cancer screening guidelines that withdrawsthe institute's recommendation that women aged 40 to

The National Cancer Institute last month added fuel to the controversyover mammography screening of women aged 40 to 49. NCI proposeda revision to its breast cancer screening guidelines that withdrawsthe institute's recommendation that women aged 40 to 49 receiveregular screening mammograms. NCI's prior guidelines, establishedin 1987, recommended mammography every one to two years and anannual clinical breast examination for women in the 40 to 49 agegroup.

The proposed guideline recommends that asymptomatic women aged40 to 49 receive a clinical breast examination annually and discussthe appropriateness of a screening mammogram individually withtheir physicians. No changes were proposed for NCI's guidelinesfor women who are 50 and over.

NCI proposed the revisions because years of research failedto show a benefit for annual screening of women between 40 and49, said Dr. Peter Greenwald in the Journal of the National CancerInstitute. Greenwald is director of NCI's Division of Cancer Preventionand Control (DCPC).

The revisions would put NCI at odds with the American CancerSociety, which recommends screening for women in the 40 to 49age group. The American College of Radiology also registered itsconcern about the proposed revisions, stating that the ACR couldnot support them.

"These proposed changes in the NCI guidelines will onlyserve to confuse women and their physicians about the benefitsof screening mammography in the earlier detection of breast cancerin all age groups," the ACR said.

The DCPC's board of scientific counselors signed off on theproposed revisions on Oct. 21 and forwarded its recommendationsto the National Cancer Advisory Board. The board will review theissue at its next meeting, on Nov. 22 and 23.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.